|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 57/00 | |
| A61K 31/66 | |||
| A01N 37/00 | |||
| A61K 31/19 | |||
| A61K 31/197 | |||
| A61K 31/4465 | |||
| A61K 38/20 | |||
| A61K 39/00 | |||
| A61K 39/39 | |||
| A61K 45/06 | |||
| A61P 3/08 | |||
| A61P 3/10 |
| (11) | Patento numeris | 2621282 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11833060.4 |
| Europos patento paraiškos padavimo data | 2011-09-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-08-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/053732 |
| Data | 2011-09-28 |
| (87) | Numeris | WO 2012/050907 |
| Data | 2012-04-19 |
| (30) | Numeris | Data | Šalis |
| 201161433089 P | 2011-01-14 | US | |
| 387398 P | 2010-09-28 | US |
| (72) |
KAUFMAN, Daniel, US
TIAN, Jide, US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
|
| (54) | GABA AGONISTS IN THE TREATMENT OF DISORDERS ASSOCIATED WITH METABOLIC SYNDROME AND GABA COMBINATIONS IN TREATMENT OR PROPHYLAXIS OF TYPE I DIABETES |
| GABA AGONISTS IN THE TREATMENT OF DISORDERS ASSOCIATED WITH METABOLIC SYNDROME AND GABA COMBINATIONS IN TREATMENT OR PROPHYLAXIS OF TYPE I DIABETES |